States have largely dismissed weakening policies, but legislatures are likely to continue considering vaccine-related bills, which may allow public health leaders to work collaboratively toward ...
Data modernization improves public health response to emerging health threats and can help address health inequities in the U.S.
On this bonus episode of Public Health Review, we chat with Stanley Campbell, CEO and CTO EagleForce. Campbell is an expert in artificial intelligence who knows how to leverage data in the fight ...
On this bonus episode, Jim Ivey, chief operating officer at Chexout, discusses the importance of interoperability and makes the case that public health organizations need to invest in software that ...
As we anticipate the likely approval of COVID-19 vaccination for children, our nation faces the final step to bring the COVID-19 pandemic under control. If approved for children ages 5-11, the ...
On this bonus episode of Public Health Review, we discuss how a business or government can create vaccine credentials that are more sophisticated than the paper cards from CDC, but that also protect ...
Our experts on this episode also discuss that while there have been perceived challenges in the initial COVID-19 vaccine rollout, the overall effort of getting vaccines into the arms of a virus that ...
Nirav Shah, Director of Maine Center for Disease Control and Prevention, and Joe Smyser, CEO of Public Good Projects, discuss countering COVID-19 vaccine misinformation.
On Aug. 23, 2021, the FDA announced full approval of Pfizer and BioNTech’s mRNA vaccine for COVID-19. ASTHO has answers to five key questions about the approval and what it means for state and ...
In recognition of National Infant Immunization Week, ASTHO and AMCHP interviewed Michael Warren, MD, MPH, FAAP, and Associate Administrator of the Maternal and Child Health Bureau (MCHB) at the ...